% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Bartos:164112,
author = {Bartos, Laura Maria and Kunte, Sebastian Thomas and
Beumers, Philipp and Xiang, Xianyuan and Wind, Karin and
Ziegler, Sibylle and Bartenstein, Peter and Choi, Hongyoon
and Lee, Dong Soo and Haass, Christian and von Baumgarten,
Louisa and Tahirovic, Sabina and Albert, Nathalie Lisa and
Lindner, Simon and Brendel, Matthias},
title = {{S}ingle cell radiotracer allocation via immunomagentic
sorting (sc{R}adiotracing) to disentangle {PET} signals at
cellular resolution.},
journal = {Journal of nuclear medicine},
volume = {63},
number = {10},
issn = {0022-3123},
address = {New York, NY},
publisher = {Soc.},
reportid = {DZNE-2022-00775},
pages = {1459-1462},
year = {2022},
abstract = {With great interest, our independent groups of scientists
located in Korea and Germany recognized the use of a very
similar methodological approach to quantify the uptake of
radioactive glucose (18F-FDG) at the cellular level. The
focus of our investigations was to disentangle microglial
18F-FDG uptake. To do so, CD11b immunomagnetic cell sorting
(MACS) was applied to isolate microglia cells after in vivo
18F-FDG injection, to allow simple quantification via gamma
counter. Importantly, this technique reveals a snapshot of
cellular glucose uptake in living mice at the time of
injection since 18F-FDG is trapped by hexokinase
phosphorylation without further opportunity to be
metabolized. Both studies indicated high 18F-FDG uptake of
single CD11b positive microglia cells and a significant
increase of microglial 18F-FDG uptake when this cell type is
activated in the presence of amyloid pathology. Furthermore,
another study investigated noticed that MACS after tracer
injection facilitated determination of high 18F-FDG uptake
in myeloid cells in a range of tumor models. Here, we aim to
discuss the rationale of single cell radiotracer allocation
via MACS (scRadiotracing) by providing examples of promising
applications of this innovative technology in neuroscience,
oncology and radiochemistry.},
keywords = {Neurology (Other) / PET (Other) / Research Methods (Other)
/ allocation (Other) / radiotracer (Other) / single cell
(Other) / sorting (Other)},
cin = {AG Tahirovic / AG Haass},
ddc = {610},
cid = {I:(DE-2719)1140003 / I:(DE-2719)1110007},
pnm = {352 - Disease Mechanisms (POF4-352)},
pid = {G:(DE-HGF)POF4-352},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:35589403},
doi = {10.2967/jnumed.122.264171},
url = {https://pub.dzne.de/record/164112},
}